NK
Insider selling
Neil Kumar sold $3.7M of BBIO stock
Neil Kumar, Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO), sold 44,980 shares of BBIO stock worth $3.7M, per an SEC Form 4 filed Aug 20, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 18, 2026, 2 days before it was made public.
BBIO has moved -9.7% since the trade date, from $82.98 to $74.95 (Oct 30, 2026 close).
- Traded
- Aug 18, 2026
- Disclosed
- Aug 20, 2026
- Filing delay
- 2 days
- Price since
- -9.7%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More BBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.